# Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia

> **NCT00148083** · PHASE3 · COMPLETED · sponsor: **University of Illinois at Chicago** · enrollment: 5 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** Risperdal Consta (drug)
- **BEHAVIORAL:** Social Skills Training

## Key facts

- **NCT ID:** NCT00148083
- **Lead sponsor:** University of Illinois at Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2006-03
- **Final completion:** 2006-03
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2019-05-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00148083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00148083, "Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00148083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*